ImmunoPrecise Antibodies Appoints Industry Veteran Jon Lieber to Board of Directors
AUSTIN, Texas--(BUSINESS WIRE)--ImmunoPrecise Antibodies Ltd. (NASDAQ: IPA) (“IPA” or the “Company”), an AI-powered biotherapeutics company, today announced the appointment of...